Dynavax Technologies said on Thursday its experimental shingles vaccine generated a similar immune response as GSK's blockbuster shot Shingrix, while showing a better safety profile, in an ...

The company said that it now intends to advance Z-1018 into the next part of the study in adults 70 years of age and older in ...

Shares of Dynavax rose after the company released positive results from a trial of its shingles vaccine tested against current Shingles vaccine Shingrix. The stock was up 6.7% to $11.12 but is still ...

Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025.

Dynavax’s lofty ambition to snatch Shingrix’s crown got off to a promising start after the biopharma’s investigational shingles vaccine held its own against GSK’s mainstay in the first part of a phase ...

The recombinant herpes zoster vaccine (Shingrix) was not only associated with a reduced risk of herpes zoster ophthalmicus ...

FOX 32's Elizabeth Matthews shares her painful and vision-threatening battle with shingles on her face and eye to raise awareness that the illness can strike younger, healthy adults.

Shingles—also known as herpes zoster—is caused by the varicella-zoster virus, the same one that causes chickenpox. If you had that malady as a kid, you’re at risk for a case of shingles ...

Shingles will strike 1 in 3 Americans during their lifetimes — most between ages 60 and 70. Folks in their 60s get shingles at roughly twice the rate as folks in their 50s, reports the CDC.

The weight of the asphalt shingles stacked on the rooftop was too much, it caused the roof and the walls to collapse, he said. "I couldn't believe it," he said. It is a modest house.

Although shingles vaccination rates have inched upward in recent years, only a third of adults who were 60 or older in 2016 had received the Zostavax vaccine, the CDC says.